The IMS Institute is now the
for Human Data Science
Reports
Featured Report
Medicine Use and Spending in the U.S. A Review of 2017 and an Outlook to 2022
Spending on medicines remains a topic of intense interest among policy makers, patients, payers and drug manufacturers. This report focuses its attention on “net spending” on medicines in the United States in 2017 with an outlook to 2022, explores out-of-pocket patient costs at pharmacies and examines the overall volume of medicines being used, with a special focus of opioids and newly launched, innovative medicines.